bioMérieux SA (EPA:BIM) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of BIM, it is a company with great financial health as well as a a strong track record of performance. In the following section, I expand a bit more on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, read the full report on bioMérieux here.

Solid track record with excellent balance sheet

Over the past year, BIM has grown its earnings by 40%, with its most recent figure exceeding its annual average over the past five years. Not only did BIM outperformed its past performance, its growth also surpassed the Medical Equipment industry expansion, which generated a 12% earnings growth. This is an optimistic signal for the future. BIM is financially robust, with ample cash on hand and short-term investments to meet upcoming liabilities. This implies that BIM manages its cash and cost levels well, which is a key determinant of the company’s health. BIM’s has produced operating cash levels of 0.78x total debt over the past year, which implies that BIM’s management has put its borrowings into good use by generating enough cash to cover a sufficient portion of borrowings.

Next Steps:

For bioMérieux, I’ve put together three relevant factors you should further examine:

1. Future Outlook: What are well-informed industry analysts predicting for BIM’s future growth? Take a look at our free research report of analyst consensus for BIM’s outlook.

2. Valuation: What is BIM worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether BIM is currently mispriced by the market.

3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of BIM? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.